StockOptionsChannel.com

Stock Options Channel is a stock options research website, aimed at financial advisors and retail investors trying to maximize the opportunities in stock options and using puts and calls to gain yield on their investments. The site includes a number of ground-breaking features that allow investors to dig deeper into interesting stock options opportunities, including the site's proprietary YieldBoost ranking system. Each week we put out a free newsletter sharing the results of our YieldBoost rankings, and throughout each day we share even more detailed reports to subscribers to our premium service. On the CALLS side of the options chain, the YieldBoost formula looks for the highest premiums a call seller can receive (expressed in terms of the extra yield against the current share price - the boost - delivered by the option premium), with strikes that are out-of-the-money with low odds of the stock being called away. On the PUTS side of the options chain, the YieldBoost formula considers that the option seller makes a commitment to put up a certain amount of cash to buy the stock at a given strike, and looks for the highest premiums a put seller can receive (expressed in terms of the extra yield against the cash commitment - the boost - delivered by the option premium), with strikes that are out-of-the-money with low odds of the stock being put to the option seller.

Recent Articles By The Author

Commit To Buy World Acceptance Corp. At $40, Earn 15.7% Annualized Using Options

Commit To Buy World Acceptance Corp. At $40, Earn 15.7% Annualized Using Options

Investors considering a purchase of World Acceptance Corp. shares, but tentative about paying the going market price of $49.05/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Commit To Buy Inotek Pharmaceuticals Corp At $7.50, Earn 41.3% Annualized Using Options

Commit To Buy Inotek Pharmaceuticals Corp At $7.50, Earn 41.3% Annualized Using Options

Investors considering a purchase of Inotek Pharmaceuticals Corp shares, but tentative about paying the going market price of $9.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $7.50 strike, which has a bid at the time of this writing of 95 cents.

Commit To Purchase Energy Recovery At $12.50, Earn 12.6% Annualized Using Options

Commit To Purchase Energy Recovery At $12.50, Earn 12.6% Annualized Using Options

Investors eyeing a purchase of Energy Recovery Inc stock, but tentative about paying the going market price of $16.04/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $12.50 strike, which has a bid at the time of this writing of $1.00.

Commit To Buy Cytokinetics At $7, Earn 12.4% Annualized Using Options

Commit To Buy Cytokinetics At $7, Earn 12.4% Annualized Using Options

Investors eyeing a purchase of Cytokinetics Inc shares, but cautious about paying the going market price of $9.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $7 strike, which has a bid at the time of this writing of 55 cents.

Commit To Purchase Sucampo Pharmaceuticals At $10, Earn 16% Annualized Using Options

Commit To Purchase Sucampo Pharmaceuticals At $10, Earn 16% Annualized Using Options

Investors considering a purchase of Sucampo Pharmaceuticals Inc stock, but tentative about paying the going market price of $13.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $10 strike, which has a bid at the time of this writing of 75 cents.